Article

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009

2020-05-12

Abstract excerpt

<h4>Background</h4> New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions, and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environment of an outbreak. We conducted a bibliometric systematic review for the 2009 influenza pandemic to determine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e1e6f20b-233e-5e31-b8d9-57f1fe6974e7
DOI: 10.1101/2020.05.07.20094839

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009DOI 10.1101/2020.05.07.20094839Read

Global landscape of randomized controlled trials responding to the COVID-19 pandemic: a literature review protocolSemantic proximity Read

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read

There Was No New Needle in the COVID Therapeutic Haystack A COVID-19 Therapeutics AnalysisSemantic proximity Read

An Overview on Drug Evolution and Trials on Pandemic COVID-19 InfectionSemantic proximity Read

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Semantic proximity Read

Developing New Drugs for the COVID-19 Emergency: Anatomy of the U.S. Response.Semantic proximity Read

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read

Inadequate Use of Antibiotics in the Covid-19 Era: Effectiveness of Antibiotic TherapySemantic proximity Read

A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study)Semantic proximity Read

Efficiency of antiviral treatment in COVID‑19Semantic proximity Read

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical SettingsSemantic proximity Read

Impact of non-pharmaceutical interventions targeted at the COVID-19 pandemic on influenza activity in the UK Armed ForcesSemantic proximity Read